Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1979 1
1982 1
1983 3
1985 2
1987 2
1988 2
1990 1
1991 1
1995 1
1996 2
1998 2
1999 1
2003 1
2005 1
2006 1
2007 1
2009 3
2010 3
2011 3
2012 1
2013 2
2014 4
2016 3
2017 1
2019 1
2020 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Giovannoni G, Boyko A, Correale J, Edan G, Freedman MS, Montalban X, Rammohan K, Stefoski D, Yamout B, Leist T, Aydemir A, Borsi L, Verdun di Cantogno E. Giovannoni G, et al. Among authors: stefoski d. Mult Scler. 2023 May;29(6):719-730. doi: 10.1177/13524585231161494. Epub 2023 Apr 3. Mult Scler. 2023. PMID: 37012898 Free PMC article.
Multiple sclerosis.
Davis FA, Stefoski D. Davis FA, et al. Among authors: stefoski d. Arch Dermatol. 1983 Feb;119(2):178-81. Arch Dermatol. 1983. PMID: 6297410 Review. No abstract available.
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.
Giovannoni G, Boyko A, Correale J, Edan G, Freedman MS, Montalban X, Rammohan K, Stefoski D, Yamout B, Leist T, Aydemir A, Borsi L, di Cantogno EV. Giovannoni G, et al. Among authors: stefoski d. Neurodegener Dis Manag. 2023 Oct;13(5):261-268. doi: 10.2217/nmt-2023-0018. Epub 2023 Aug 3. Neurodegener Dis Manag. 2023. PMID: 37535336 Free article. Review.
Treatment of natalizumab-associated PML with filgrastim.
Stefoski D, Balabanov R, Waheed R, Ko M, Koralnik IJ, Sierra Morales F. Stefoski D, et al. Ann Clin Transl Neurol. 2019 Apr 8;6(5):923-931. doi: 10.1002/acn3.776. eCollection 2019 May. Ann Clin Transl Neurol. 2019. PMID: 31139690 Free PMC article.
Hematopoietic stem cell transplantation for multiple sclerosis.
Burt RK, Cohen B, Rose J, Petersen F, Oyama Y, Stefoski D, Katsamakis G, Carrier E, Kozak T, Muraro PA, Martin R, Hintzen R, Slavin S, Karussis D, Haggiag S, Voltarelli JC, Ellison GW, Jovanovic B, Popat U, McGuirk J, Statkute L, Verda L, Haas J, Arnold R. Burt RK, et al. Among authors: stefoski d. Arch Neurol. 2005 Jun;62(6):860-4. doi: 10.1001/archneur.62.6.860. Arch Neurol. 2005. PMID: 15956156 Review. No abstract available.
Glioblastoma in natalizumab-treated multiple sclerosis patients.
Sierra Morales F, Wright RB, Novo JE, Arvanitis LD, Stefoski D, Koralnik IJ. Sierra Morales F, et al. Among authors: stefoski d. Ann Clin Transl Neurol. 2017 Jun 6;4(7):512-516. doi: 10.1002/acn3.428. eCollection 2017 Jul. Ann Clin Transl Neurol. 2017. PMID: 28695151 Free PMC article.
Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum.
Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF. Guo Y, et al. Among authors: stefoski d. JAMA Neurol. 2014 Aug;71(8):1025-9. doi: 10.1001/jamaneurol.2014.775. JAMA Neurol. 2014. PMID: 24911400
Freedom from disease activity in multiple sclerosis.
Havrdova E, Galetta S, Stefoski D, Comi G. Havrdova E, et al. Among authors: stefoski d. Neurology. 2010 Apr 27;74 Suppl 3:S3-7. doi: 10.1212/WNL.0b013e3181dbb51c. Neurology. 2010. PMID: 20421571
50 results